Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. - Wikidata - awgldk - TriplyDB

Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.

Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.

http://www.wikidata.org/entity/Q35749606

about

Invariant NKT cells as novel targets for immunotherapy in solid tumors The role of NKT cells in tumor immunity The transcription factor PLZF directs the effector program of the NKT cell lineage Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents iNKT Cells and Their Potential Lipid Ligands during Viral Infection Turned on by danger: activation of CD1d-restricted invariant natural killer T cells The immunoregulatory role of type I and type II NKT cells in cancer and other diseases Crystal Structures of Mouse CD1d-iGb3 Complex and its Cognate Vα14 T Cell Receptor Suggest a Model for Dual Recognition of Foreign and Self Glycolipids Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.CD1d protein structure determines species-selective antigenicity of isoglobotrihexosylceramide (iGb3) to invariant NKT cells Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease.V(alpha)14iNKT cells promote liver pathology during adenovirus infection by inducing CCL5 production: implications for gene therapy.NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines.[Globosides as key players in the pathophysiology of Shiga toxin-associated acute kidney failure and Fabry disease].Recognition of lyso-phospholipids by human natural killer T lymphocytes.Linking inflammation to natural killer T cell activation.Stimulation of natural killer T cells by glycolipids Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells CD1: A Singed Cat of the Three Antigen Presentation Systems.NKT cells at the maternal-fetal interface.Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d [corrected]Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cells Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease.Multi-system disorders of glycosphingolipid and ganglioside metabolism Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid Cytokine dependent and independent iNKT cell activation Invariant NKT cell development requires a full complement of functional CD3 zeta immunoreceptor tyrosine-based activation motifs The effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells.NKT cells in sepsis.T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire Transcriptional control of invariant NKT cell development.Depletion of globosides and isoglobosides fully reverts the morphologic phenotype of Fabry disease Invariant natural killer T cells as sensors and managers of inflammation.

P2860

Q21284987-7450AFD5-26E0-445B-8FA1-E13B0F610592 Q24648939-16C25E50-CB30-4D5D-8AFE-2E5D88FD8472 Q24654999-2AF6D8BF-77AA-427F-91AE-1F120E79530F Q26748456-434FAF68-C271-427B-BC1D-3584691ACB3F Q26800120-A7D21140-D25D-40F6-B551-03902ABD343F Q26825059-FB7C7759-849F-4A7A-ABEA-CEE8E743B54F Q27027556-8B9FD2B5-98ED-4508-82AF-8702C406DC80 Q27649921-F9D25BF9-A431-4023-B050-9458EBBB9FF4 Q27671299-B3CB1375-921A-4602-A0AA-5D985C23A0ED Q28119060-E5C5F009-91FB-4A23-89C4-282AFA3E8E10 Q28505051-203A44C2-BADC-4B9F-B5D1-1BD360F18CF2 Q28511526-79ED41A7-8109-4950-9E1A-22A85EAB51F9 Q28584907-84938459-71ED-4A21-A68C-E3F131AFFFD9 Q30408873-F0C8898B-2920-4DC2-8E85-D714DFB95579 Q30425388-947DEB8D-40EB-4B82-AF47-C97E83786843 Q30429393-465778B0-9EE8-494B-9F18-A113FEC700D7 Q30433085-3B3DFCD1-EEB3-4400-B1BA-6270FA07F761 Q30435470-1F088739-7434-4D2F-A0CC-9FA7B620529B Q33418419-6941A102-29B3-40EF-8896-A0BDDCD4EEB6 Q33512901-5EE8E469-6652-4D87-87DD-FF695B25DF85 Q33512902-9EFF4131-B59B-4AA5-904D-154E01E379A1 Q33599059-2E4950EB-058A-4DA6-BEAD-0AC9CC8CC945 Q33599438-137AC5A6-17E9-4002-81DD-37F2A4C6328F Q33695019-DAAE83FD-FC7D-4D72-817B-6A09AAF99FCF Q33699698-5D792A5A-215D-4D1A-AE2D-022704B12FB6 Q33720359-A56D8D5A-0FEB-4458-A29B-249750303ED6 Q33724575-C67C68A5-D475-4175-BB6B-978C7CC33A8D Q33733888-F38AAF8A-F263-4335-AD76-A44F76DF786A Q33745321-F9013D27-86CE-4F81-A4E0-E5B0D4E8F208 Q33902002-18CA9634-BBB5-4241-900A-3A3A999E0642 Q33902037-6E6B66FF-4E44-4A3B-B1EE-31C4A20AB3EC Q33934639-DBB5EAC8-126C-4802-AC57-AF9F0BE81C3A Q34039891-C09B9AF6-187C-4D96-A7D5-798AB526E242 Q34162876-BFB4F6D7-604B-4B49-9F3A-37A621EBD897 Q34179888-2200A94C-9281-4DBB-9FEB-A9208472523B Q34189487-377429CE-7783-4470-9EEC-8D1F747AD297 Q34245603-838AD186-87E8-4917-85AA-90E6BC73D971 Q34248566-4199A473-AE6C-4FAF-BCC2-BE3FEBBB72BF Q34294988-D92342C1-DC7D-4727-9616-82CA40857989 Q34302295-C91E4B1C-E871-4E46-A6BC-FFC34D55B1CD

P2860

Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.

http://www.wikidata.org/entity/Q35749606

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Normal development and functio ...... sylceramide (iGb3) deficiency.

@ast

Normal development and functio ...... sylceramide (iGb3) deficiency.

@en

type

label

Normal development and functio ...... sylceramide (iGb3) deficiency.

@ast

Normal development and functio ...... sylceramide (iGb3) deficiency.

@en

prefLabel

Normal development and functio ...... sylceramide (iGb3) deficiency.

@ast

Normal development and functio ...... sylceramide (iGb3) deficiency.

@en

P1433

Q35749606-989460EA-483E-4843-9CB3-15012F930E22

P1476

Q35749606-09AC0639-5392-433E-B782-57CAE99207B7

P2093

Q35749606-6D6EF2BD-2627-4445-8576-514BB2FF7F04

Q35749606-B2A91ADF-086D-427E-92AE-C3114E06F4DD

P2860

Q35749606-05A1D856-DEFC-4A33-8422-6AC1E17FD8B3

Q35749606-06EE9DC5-681E-4F9C-BBDE-6B40F638D52A

Q35749606-081368AB-1CE8-4A9B-96FB-314859EE5ABA

Q35749606-0EAFB148-2FAD-4D74-BCF9-ECADE146C55E

Q35749606-1793EF38-60C9-4646-A728-DC1A784FAA7A

Q35749606-1B1C167B-7B64-4A40-AA53-C486EC2DF764

Q35749606-21A8BE3D-323F-44E1-88CF-5014BDABA833

Q35749606-23969932-0BCC-4E15-929A-ECC9DFAC149E

Q35749606-24F89B58-CDAF-4F00-8B83-34AE43368669

Q35749606-2E398C28-AC36-4D79-8723-5311DF468711

P304

Q35749606-25BFFE0B-6AEA-40DE-AA36-B6E54C4C3A50

P31

Q35749606-34CCAC0C-9492-4022-B966-AE9919A28D12

P356

Q35749606-FD3E7A2F-3C9E-489B-9172-A1184E12BE87

P407

Q35749606-44F26BC4-FE0D-45E8-8056-960DD46D56DA

P433

Q35749606-D13DB0DD-47B6-4A6B-9E85-A90C321AE7F4

P478

Q35749606-68D7E95E-D30A-4B51-B831-673818727850

P50

Q35749606-2144D6E0-BBB0-4DED-B2AE-62EB7983A73E

Q35749606-6D69B0FD-C576-4195-B5E9-83B1784BDF8B

Q35749606-A615B6B4-EAD2-4DAC-8314-AAAD8C06D6C2

Q35749606-AC6EB5A5-7007-4CA2-BB4A-CCAD315797F0

P577

Q35749606-4DB7DC74-69B8-485E-85E6-BFECD87FED3D

P5875

Q35749606-D2DF6794-3E22-4759-8AAC-06A5ED0A9ACF

P698

Q35749606-B5B14527-52D5-4AF1-953F-6C759253A275

P932

Q35749606-8EACE2A4-81E3-420A-AC9F-6704E500EE5C

P356

PNAS.0611139104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Normal development and functio ...... sylceramide (iGb3) deficiency.

@en

P2093

Bruno Luckow

http://www.w3.org/2001/XMLSchema#string

Hermann-Josef Gröne

http://www.w3.org/2001/XMLSchema#string

P2860

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Activity of the yeast MNN1 alpha-1,3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases

CD1: antigen presentation and T cell function

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

Expression cloning of a new member of the ABO blood group glycosyltransferases, iGb3 synthase, that directs the synthesis of isoglobo-glycosphingolipids

Characterization of the rat alpha(1,3)galactosyltransferase: evidence for two independent genes encoding glycosyltransferases that synthesize Galalpha(1,3)Gal by two separate glycosylation pathways

A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells

The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids.

Invariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice.

Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.

P304

5977-5982

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0611139104

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Vincenzo Cerundolo

Anneliese O Speak

P577

2007-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6435593

http://www.w3.org/2001/XMLSchema#string

P698

17372206

http://www.w3.org/2001/XMLSchema#string

P932

1851602

http://www.w3.org/2001/XMLSchema#string